ArticleCancer discovery2022

Dietary Lactobacillus-Derived Exopolysaccharide Enhances Immune-Checkpoint Blockade Therapy.

Hirotaka Kawanabe-Matsuda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.